Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000291873 | SCV000341138 | likely benign | not specified | 2017-04-12 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000291873 | SCV000595650 | uncertain significance | not specified | 2016-06-13 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001085157 | SCV000652638 | benign | Combined immunodeficiency due to LRBA deficiency | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Blueprint Genetics | RCV000788151 | SCV000927173 | uncertain significance | not provided | 2017-02-24 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000788151 | SCV001500326 | likely benign | not provided | 2022-12-01 | criteria provided, single submitter | clinical testing | LRBA: BS2 |
Mayo Clinic Laboratories, |
RCV000788151 | SCV001714721 | uncertain significance | not provided | 2020-03-20 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003949897 | SCV004764329 | likely benign | LRBA-related condition | 2023-07-06 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Diagnostic Laboratory, |
RCV000788151 | SCV001742924 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000788151 | SCV001965007 | uncertain significance | not provided | no assertion criteria provided | clinical testing |